<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39437795</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-7176</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of clinical hypertension (Greenwich, Conn.)</Title><ISOAbbreviation>J Clin Hypertens (Greenwich)</ISOAbbreviation></Journal><ArticleTitle>May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/jch.14919</ELocationID><Abstract><AbstractText>We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1-min interval in the sitting position, using a validated automated BP monitor (Omron HEM-7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n  =  29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n =  1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p &lt; 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p &lt; 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p &lt; 0.05), and overweight (+1.8/+1.4 mm Hg, p &lt; 0.001) and obesity (+2.3/+1.5 mm Hg, p &lt; 0.001). In conclusion, our study provided unique blood pressure data during the COVID-19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies.</AbstractText><CopyrightInformation>© 2024 The Author(s). The Journal of Clinical Hypertension published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-7970-6991</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li-Ping</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital of Shanxi Datong University, Shanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao-Long</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Cardiology, People's Hospital of Hongsibao District, Ningxia, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ning-Ru</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Bengbu Medical University, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Lanzhou University Second Hospital, Gansu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Li-Ying</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Forth People's Hospital of Datong City, Shanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tong-She</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Luoyang Dongfang People's Hospital, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, People's Hospital of Ningxia Hui Autonomous Region, Ningxia, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ya-Min</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cangzhou Central Hospital, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First People's Hospital of Zunyi, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Qi-Dong</ForeName><Initials>QD</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yuhuan Second Peoples' Hospital, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5825-5968</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ji-Guang</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82070432</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>82070435</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>82270469</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>82370426</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>2018YFC1704902</GrantID><Agency>the Ministry of Science and Technology</Agency><Country /></Grant><Grant><GrantID>2022YFC3601302</GrantID><Agency>the Ministry of Science and Technology</Agency><Country /></Grant><Grant><GrantID>19DZ2340200</GrantID><Agency>the Shanghai Municipal Commissions of Science and Technology</Agency><Country /></Grant><Grant><GrantID>2022LJ022</GrantID><Agency>the Shanghai Municipal Commissions of Science and Technology</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Hypertens (Greenwich)</MedlineTA><NlmUniqueID>100888554</NlmUniqueID><ISSNLinking>1524-6175</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood pressure</Keyword><Keyword MajorTopicYN="N">control</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">screening</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39437795</ArticleId><ArticleId IdType="doi">10.1111/jch.14919</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>X. Chen, S. K. Xu, Y. Li, et al., “May Measurement Month 2017: An Analysis of Blood Pressure Screening Results in China—East Asia,” European Heart Journal Supplements 21, no. Suppl D (2019): D37–D39.</Citation></Reference><Reference><Citation>X. Chen, S. K. Xu, Q. H. Guo, et al., “Barriers to Blood Pressure Control in China in a Large Opportunistic Screening,” Journal of Clinical Hypertension 22 (2020): 835–841.</Citation></Reference><Reference><Citation>X. Chen, Y. Li, Z. Hu, et al., “May Measurement Month 2018: An Analysis of Blood Pressure Screening Results From China,” European Heart Journal Supplements 22, no. Suppl H (2020): H40–H42.</Citation></Reference><Reference><Citation>X. Chen, C. Y. Liu, L. Y. Xu, et al., “May Measurement Month 2019: An Analysis of Blood Pressure Screening Results From China,” European Heart Journal Supplements 23, no. Suppl B (2021): B43–B45.</Citation></Reference><Reference><Citation>T. Beaney, A. E. Schutte, G. S. Stergiou, et al., “May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension,” Hypertension 76, no. 2 (2020): 333–341.</Citation></Reference><Reference><Citation>H. Li, X. Wei, M. C. Wong, et al., “A Comparison of the Quality of Hypertension Management in Primary Care Between Shanghai and Shenzhen: A Cohort Study of 3196 Patients,” Medicine 94 (2015): e455.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>